#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	8786	16S	1529	1529	100.0	16S.l15.c17.ctg.1	2051	418.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1414	1414	C	491	C	485	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	8786	16S	1529	1529	100.0	16S.l15.c17.ctg.1	2051	418.1	0	HET	.	.	.	G395A	.	395	395	G	625	625	G	489	G,A	361,123	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	15672	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3647	423.7	0	.	n	.	0	T695C	SNP	695	695	T	1085	1085	C	447	C	443	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	15672	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3647	423.7	0	.	n	.	0	G1337A	SNP	1337	1337	G	1727	1727	A	498	A,G	492,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	15672	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3647	423.7	0	.	n	.	0	T1971C	SNP	1971	1971	T	2361	2361	C	507	C	495	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	15672	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3647	423.7	1	SNP	n	A2045G	0	.	.	2045	2045	A	2435	2435	A	497	A	491	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	15672	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3647	423.7	1	SNP	n	C2597T	0	.	.	2597	2597	C	2987	2987	C	480	C,T	465,7	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	1230	folP	855	855	100.0	folP.l15.c4.ctg.1	1587	76.2	1	SNP	p	R229S	1	.	.	685	687	AGC	1110	1112	AGC	130;134;135	A;G;C	127;129;127	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3306	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3530	92.5	1	SNP	p	S91F	1	.	.	271	273	TTC	697	699	TTC	103;102;103	T;T;C	100;100;99	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3306	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3530	92.5	1	SNP	p	D95G	1	.	.	283	285	GGC	709	711	GGC	94;94;96	G;G;C	92;93;95	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3306	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3530	92.5	1	SNP	p	G95N	0	.	.	283	285	GGC	709	711	GGC	94;94;96	G;G;C	92;93;95	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	1102	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1460	74.6	1	SNP	p	G45D	0	.	.	133	135	GGC	477	479	GGC	115;113;110	G;G,A;C	113;110,2;109	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	558	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1028	53.7	0	.	n	.	0	A197.	DEL	197	197	A	633	633	A	125	A	123	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3008	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3065	96.8	1	SNP	p	D86N	0	.	.	256	258	GAC	651	653	GAC	135;135;136	G;A;C	133;130;134	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3008	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3065	96.8	1	SNP	p	R87I	0	.	.	259	261	CGT	654	656	CGT	136;135;135	C,A;G;T	132,1;131;129	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3008	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3065	96.8	1	SNP	p	R87W	0	.	.	259	261	CGT	654	656	CGT	136;135;135	C,A;G;T	132,1;131;129	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3008	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3065	96.8	1	SNP	p	S87R	1	.	.	259	261	CGT	654	656	CGT	136;135;135	C,A;G;T	132,1;131;129	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3008	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3065	96.8	1	SNP	p	S88P	0	.	.	262	264	TCC	657	659	TCC	136;136;135	T;C;C	131;131;132	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	2478	parE	1986	1986	100.0	parE.l6.c30.ctg.1	2781	88.0	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1608	1610	GGC	128;127;123	G;G;C	123;122;120	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.002	penA.2.002	1	1	27	2268	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2262	97.8	1	SNP	p	A311V	0	.	.	931	933	GCA	1166	1168	GCA	132;133;135	G,T;C;A	128,1;127;133	penA.2.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	2268	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2262	97.8	1	SNP	p	I312M	0	.	.	934	936	ATC	1169	1171	ATC	135;136;137	A;T;C	134;133;133	penA.2.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	2268	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2262	97.8	1	SNP	p	V316P	0	.	.	946	948	GTG	1181	1183	GTG	142;143;144	G;T;G	142;142;141	penA.2.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	2268	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2262	97.8	1	SNP	p	V316T	0	.	.	946	948	GTG	1181	1183	GTG	142;143;144	G;T;G	142;142;141	penA.2.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	2268	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2262	97.8	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1685	1687	ACC	112;111;111	A;C;C	105;110;110	penA.2.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	2268	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2262	97.8	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1739	1741	GCG	108;107;107	G;C,G;G	102;92,2;105	penA.2.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	2268	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2262	97.8	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1739	1741	GCG	108;107;107	G;C,G;G	102;92,2;105	penA.2.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	2268	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2262	97.8	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1862	1864	GGC	84;82;82	G;G;C	79;77;77	penA.2.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	2268	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2262	97.8	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1871	1873	GGC	75;75;74	G;G;C	69;68;71	penA.2.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	2268	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2262	97.8	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1889	1891	CCG	51;51;48	C;C;G	51;51;44	penA.2.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	3376	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3110	106.8	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1601	1603	CCG	125;123;122	C;C,T;G	116;115,3;116	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1384	porA	1146	1146	99.91	porA.l15.c17.ctg.1	1908	71.2	0	.	p	.	0	M83fs	FSHIFT	247	247	A	538	538	C	90	C	86	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	1704	porB1b	1035	1035	98.57	porB1b.l6.c4.ctg.1	1649	101.9	0	.	p	.	0	E48G	NONSYN	142	144	GAA	463	465	GGA	135;133;132	G;G,A;A	132;130,1;130	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	1704	porB1b	1035	1035	98.57	porB1b.l6.c4.ctg.1	1649	101.9	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	952	952	T	140	T	129	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	1704	porB1b	1035	1035	98.57	porB1b.l6.c4.ctg.1	1649	101.9	1	SNP	p	G120K	0	.	.	358	360	GGT	679	681	GGT	115;112;110	G,A;G,A;T,G	109,2;108,2;98,2	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	1704	porB1b	1035	1035	98.57	porB1b.l6.c4.ctg.1	1649	101.9	1	SNP	p	A121D	0	.	.	361	363	GCC	682	684	GCC	110;110;109	G,A;C,A;C	107,1;105,2;105	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	1704	porB1b	1035	1035	98.57	porB1b.l6.c4.ctg.1	1649	101.9	1	SNP	p	A121N	0	.	.	361	363	GCC	682	684	GCC	110;110;109	G,A;C,A;C	107,1;105,2;105	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	5886	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5047	114.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	680	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1064	62.4	1	SNP	p	V57M	1	.	.	169	171	ATG	453	455	ATG	128;128;128	A,C;T;G	124,1;126;125	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
